Target intelligence / Profile preview

U3 small nucleolar ribonucleoprotein protein IMP3 (IMP3)

Target
IMP3
Molecular classification
Other (Small nucleolar ribonucleoprotein component, S4 family)
01

Overview

U3 small nucleolar ribonucleoprotein protein IMP3 (IMP3) is a protein component of the U3 small nucleolar ribonucleoprotein complex, primarily involved in pre-rRNA processing for the maturation of the small ribosomal subunit (18S rRNA) in eukaryotes[1][2][3]. IMP3 contains an S4 domain and is an essential nucleolar protein required for the correct cleavage of pre-rRNA at specific sites (A0, A1, A2), thereby ensuring accurate ribosome biogenesis[1][2][3]. IMP3 acts by unfolding structured regions in pre-rRNA and U3 snoRNA, promoting their hybridization, which signals for subsequent cleavage necessary for ribosome assembly[2]. IMP3 is not considered a therapeutic target (receptor, enzyme, etc.), has no associated approved drugs, and is mainly classified as an essential biogenesis factor rather than a disease-associated protein[1][2][3].

Other names
U3 snoRNP protein IMP3IMP3C15orf12MRPS4FLJ10968BRMS2U3 small nucleolar ribonucleoprotein 3U3 snoRNP protein 3 homolog
02

Biological functions

Ribosome biogenesisPre-rRNA processing
03

Disease associations

Other (no direct role in cancer, inflammation, or other major disease areas documented)

Beyond the preview

Go deeper on U3 small nucleolar ribonucleoprotein protein IMP3 (IMP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U3 small nucleolar ribonucleoprotein protein IMP3 (IMP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call